Conclusions
death, SARS-CoV-2 infection
SARS-COV-2 INFECTION
In this population-based study, the BNT162b2 vaccine appears to be more efficacious than the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 infection and hospitalisation for COVID-19 but not death from COVID-19.